Non-Hodgkin Lymphoma: Classification, Symptoms, Diagnosis, and Treatment — Practice Questions | Essay Questions | Ompath Study

Practice 6 structured short- and long-answer medical questions on Non-Hodgkin Lymphoma: Classification, Symptoms, Diagnosis, and Treatment — Practice Questio...

Essay Questions and Answers

  1. Q1. A 55-year-old male presents with a several-month history of painless, asymmetric cervical lymphadenopathy. A lymph node biopsy is performed. What key diagnostic step is crucial after biopsy for confirming the clonality of a B-cell NHL, and what specific finding would support this?
  2. Q2. A 60-year-old patient is diagnosed with Follicular Lymphoma. Based on the WHO classification and grading mentioned in the article, describe two characteristic features of this specific NHL subtype regarding its course and curability.
  3. Q3. A patient is diagnosed with a high-grade B-cell lymphoma and presents with fever, night sweats, and unexplained weight loss. Beyond these specific symptoms, identify two other common sites of extranodal involvement for NHL, as described in the article.
  4. Q4. A 45-year-old patient is diagnosed with Diffuse Large B-cell Lymphoma (DLBCL). What is the standard first-line chemotherapy regimen for this subtype, and what specific type of monoclonal antibody is typically included in this regimen, based on the article?
  5. Q5. A patient undergoing investigation for suspected NHL has elevated lactate dehydrogenase (LDH). What is the significance of elevated LDH in the context of NHL investigations, as stated in the article?
  6. Q6. A 68-year-old male presents with a several-week history of worsening fatigue, drenching night sweats, and a 10% unintentional weight loss over the past three months. Physical examination reveals asymmetric, firm, non-tender cervical and axillary lymphadenopathy. He also reports vague abdominal discomfort. A tru-cut biopsy of an enlarged lymph node confirms a diagnosis of Non-Hodgkin Lymphoma (NHL). Discuss the key diagnostic investigations, significant cytogenetic findings for common aggressive and indolent subtypes, and general treatment principles for NHL, using information solely from the provided article.
View on OmpathStudy